Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Sensitization after kidney transplantation.

Enver Akalin¹, Manuel Pascual

¹Renal Division and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1104, New York, NY 10029, USA. enver.akalin@msnyuhealth.org

Clinical Journal of the American Society of Nephrology : CJASN

|August 21, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026

Same author

Fulminant Acanthamoeba Encephalitis Diagnosed By Cell-Free DNA in a Renal Transplant Patient: A Case Report.

Transplantation proceedings·2026

Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026

Same author

Impact of Disease Recurrence and Outcomes following Kidney Transplantation for Glomerulonephritis: A Prospective Nationwide Cohort Study.

Kidney360·2026

Same author

Impact of older donor age in kidney transplants in a biopsy-based observational study.

JCI insight·2026

Same author

A New Costimulatory Blockage Agent in the Pipeline.

Transplantation·2026

Same journal

A Patient's Perspective on Arteriovenous Fistula Care and Far-Infrared Radiation Arteriovenous Fistula Therapy.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same journal

A Beacon of Hope: Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same journal

Sequential Biomarker Testing in Kidney Transplant Surveillance: How Far Does One Step at a Time Take Us?

Clinical journal of the American Society of Nephrology : CJASN·2026

Same journal

The Predicting Risk of Cardiovascular Disease Event Equation Meets CKD.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same journal

Muscle Cramp Rate, Severity and Burden in Maintenance Hemodialysis Patients: A Yearlong Multicenter Quality Improvement Initiative.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same journal

From Risk Determinants to Clinical Action: Understanding and Implementing the Cardiovascular Kidney Metabolic Syndrome Framework.

Clinical journal of the American Society of Nephrology : CJASN·2026

See all related articles

Kidney transplant recipients can develop antibodies that risk rejection and reduce graft survival. Monitoring these antibodies post-transplant helps identify high-risk patients and guide treatment for better outcomes.

Area of Science:

Immunology
Transplantation Science
Nephrology

Background:

Kidney transplant recipients are susceptible to developing de novo anti-HLA and non-HLA antibodies post-transplantation.
The presence of these antibodies, whether donor-specific or not, elevates the risk of acute and chronic rejection, compromising allograft survival.

Purpose of the Study:

To highlight the significance of detecting anti-HLA and non-HLA antibodies in kidney transplant recipients.
To emphasize the role of advanced detection methods in identifying high-risk patients.
To underscore the importance of post-transplant antibody monitoring for guiding therapeutic interventions.

Main Methods:

Utilizing sensitive and specific methods like Flow Specific Beads and FlowPRA for antibody detection.

Related Experiment Videos

Implementing pre- and post-transplantation antibody screening.

Monitoring anti-HLA antibody production over time.

Main Results:

Sensitive detection methods aid in defining immunologically high-risk kidney transplant recipients.
Post-transplantation monitoring identifies patients at risk for late allograft failure.
Alloantibody status informs the judicious use of immunomodulatory agents.

Conclusions:

Early identification and monitoring of antibody production are crucial for managing kidney transplant recipients.
Advanced antibody detection techniques improve risk stratification and patient management.
Personalized immunomodulatory therapy based on alloantibody status can enhance long-term allograft survival.